Acquisition by Straw Edward M of 10732 shares of Helius Medical at 0.7292 subject to Rule 16b-3
| FORZ Stock | USD 0.0001 0.00 0.00% |
Slightly above 56% of Forza Innovations' investor base is looking to short. The analysis of overall sentiment of trading Forza Innovations pink sheet suggests that many investors are alarmed at this time. Forza Innovations' investing sentiment can be driven by a variety of factors including economic data, Forza Innovations' earnings reports, geopolitical events, and overall market trends.
Forza |
Filed transaction by Helius Medical Technologies Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Forza Innovations Fundamental Analysis
We analyze Forza Innovations' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Forza Innovations using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Forza Innovations based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
Forza Innovations is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Forza Innovations Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Forza Innovations pink sheet to make a market-neutral strategy. Peer analysis of Forza Innovations could also be used in its relative valuation, which is a method of valuing Forza Innovations by comparing valuation metrics with similar companies.
Peers
Forza Innovations Related Equities
| QIPT | Quipt Home | 4.75 | ||||
| TELA | Tela Bio | 2.83 | ||||
| RSLS | ReShape Lifesciences | 1.27 | ||||
| ABT | Abbott Laboratories | 0.75 | ||||
| PROF | Profound Medical | 0.26 | ||||
| MYO | Myomo | 1.00 | ||||
| TMCI | Treace Medical | 1.05 | ||||
| LUNG | Pulmonx Corp | 1.82 | ||||
| NUWE | Nuwellis | 3.60 | ||||
| MASS | 908 Devices | 5.16 | ||||
| SINT | SINTX Technologies | 7.53 | ||||
| BBLG | Bone Biologics | 8.18 | ||||
| HSDT | Helius Medical | 8.22 |
Additional Tools for Forza Pink Sheet Analysis
When running Forza Innovations' price analysis, check to measure Forza Innovations' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forza Innovations is operating at the current time. Most of Forza Innovations' value examination focuses on studying past and present price action to predict the probability of Forza Innovations' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forza Innovations' price. Additionally, you may evaluate how the addition of Forza Innovations to your portfolios can decrease your overall portfolio volatility.